Autologous hematopoietic stem cell transplantation for autoimmune diseases: An observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases

Haematologica

Volumn 95, Issue 2, 2010, Pages 284-292

  Farge, Dominique ^a   Labopin, Myriam ^b   Tyndall, Alan ^c   Fassas, Athanasios ^d   Mancardi, Gian Luigi ^e   Van Laar, Jaap ^f   Ouyang, Jian ^g   Kozak, Tomas ^h   Moore, John ⁱ   Kötter, Ina ^j   Chesnel, Virginie ^k   Marmont, Alberto ^l   Gratwohl, Alois ^m   Saccardi, Riccardo ⁿ  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c Rheumatology   (Switzerland)

^d George Papanicolau Hospital   (Greece)

^e UNIVERSITY OF GENOA   (Italy)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

^g Nanjing Hospital   (China)

^h CHARLES UNIVERSITY   (Czech Republic)

ⁱ ST VINCENT S HOSPITAL   (Australia)

^j UNIVERSITY OF TÜBINGEN   (Germany)

^k CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^l UNIVERSITY OF GENOA   (Italy)

^m Kantonsspital   (Switzerland)

ⁿ UO Ematologia   (Italy)

more..

Author keywords

Antithymocyte globulins; Autoimmune diseases; Autologous hematopoietic stem cell transplantation; Cyclophosphamide; Hematologic immune cytopenia; Juvenile idiopathic arthritis; Multiple sclerosis; Rheumatoid arthritis; Systemic lupus erythematosus; Systemic sclerosis; Total body irradiation

Indexed keywords

BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUDARABINE; MELPHALAN; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHILD; CLINICAL TRIAL; CYTOPENIA; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC IMMUNE CYTOPENIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE SCLEROSIS; OVERALL SURVIVAL; PRESCHOOL CHILD; PROGRESSION FREE SURVIVAL; RHEUMATOID ARTHRITIS; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; AUTOIMMUNE DISEASES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE-FREE SURVIVAL; EUROPE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 76549116862     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.013458     Document Type: Article

References (43)

1. Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001;345(5):340-50.
2. Sykes M, Nikolic B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature. 2005;435(7042):620-7.
3. Marmont A, Tyndall A, Gratwohl A, Vischer T. Haemopoietic precursor-cell transplants for autoimmune diseases. Lancet. 1995;345:978.
4. Tyndall A, Gratwohl A. Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases. Ann Rheum Dis. 1996;55(3):149-51.
5. Ikehara S, Yasumizu R, Inaba M, Izui S, Hayakawa K, Sekita K, et al. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA. 1989;86(9):3306-10.
6. Van Bekkum DW. Stem cell transplantation for autoimmune disorders. Preclinical experiments. Best Pract Res Clin Haematol. 2004;17(2):201-22.
7. Tyndall A, Black C, Finke J, Winkler J, Mertlesmann R, Peter HH, Gratwohl A. Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet. 1997;349(9047):254.
8. Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge D, et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant. 2005;35(9):869-79.
9. Farge D, Passweg J, van Laar JM, Marjanovic Z, Besenthal C, Finke J, et al. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann Rheum Dis. 2004;63(8):974-81.
10. Vonk MC, Marjanovic Z, van den Hoogen FH, Zohar S, Schattenberg AV, Fibbe WE, et al. Long-term follow-up results after autologous hematopoietic stem cell transplantation for the treatment of severe systemic sclerosis. Ann Rheum Dis. 2008; 67(1):98-104.
11. Nash RA, McSweeney PA, Crofford LJ, Abidi M, Chen CS, Godwin JD, et al. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. Blood. 2007;110(4):1388-96.
12. Farge D, Nash R, Laar JM. Autologous stem cell transplantation for systemic sclerosis. Autoimmunity. 2008;41(8):616-24.
13. Saccardi R, Kozak T, Bocelli-Tyndall C, Fassas A, Kazis A, Havrdova E, et al. Autoimmune Diseases Working Party of EBMT. Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Mult Scler. 2006;12(6):814-23.
14. Jayne D, Passweg J, Marmont A, Farge D, Zhao X, Arnold R, et al. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus. 2004;13(3):168-76.
15. Burt RK, Traynor A, Statkute L, Barr WG, Rosa R, Schroeder J, et al. Non myeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA. 2006;295(5):527-35.
16. Marmont A, Burt R. Hematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphopholipid syndrome and bullous skin diseases. Autoimmunity. 2008;41(8):639-47.
17. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-7.
18. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18(6):695-706.
19. Fine JP, Gray RJ. A proportional hazards model for subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496-509.
20. Hough RE, Snowden JA, Wulffraat NM. Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective. Br J Haematol. 2005;128(4):432-59.
21. Mancardi G, Saccardi R. Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurol. 2008; 7(7):626-36.
22. Burt RK, Loh Y, Cohen B, Stefosky D, Balabanov R, Katsamakis G, et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Lancet Neurol. 2009;8(3):244-53.
23. Wulffraat N, van Royen A, Bierings M, Vossen J, Kuis W. Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis. Lancet. 1999;353(9152):550-3.
24. de Kleer I, Vastert B, Klein M, Teklenburg G, Arkesteijn G, Puga Yung, et al. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+ CD25+ immune regulatory network Blood. 2006; 107(4):1696-702.
25. Moore J, Brooks P, Milliken S, Biggs J, Ma D, Handel M, et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum. 2002;46(9):2301-9.
26. Passweg JR, Rabusin M, Musso M, Beguin Y, Cesaro S, Ehninger G, et al. Autoimmune Disease Working Party of the EBMT. Haematopoetic stem cell transplantation for refractory autoimmune cytopenia. Br J Haematol. 2004;125(6):749-55.
27. Hawkey CJ, Snowden JA, Lobo A, Beglinger C, Tyndall A. Stem cell transplantation for inflammatory bowel disease: practical and ethical issues. Gut. 2000; 46(6):869-72.
28. Daikeler T, Kötter I, Bocelli Tyndall C, Apperley J, Attarbaschi A, Guardiola P, et al. EBMT Autoimmune Diseases Working Party. Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature. Ann Rheum Dis. 2007;66(2):202-7.
29. Nannini C, West CP, Erwin PJ, Matteson EL. Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and a meta analysis of randomized controlled trials and observational prospective cohorts. Arthritis Res Ther. 2008;10(5):R124.
30. Lorenzi AR, Clarke AM, Wooldridge T, Waldmann H, Hale G, Symmons D, et al. Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomes. Arthritis Rheum. 2008;58(2):370-5.
31. Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR. et al. Predicting mortality in systemic sclerosis. Analysis of cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine. 2002;81(2):154-67.
32. Doria A, Laccarino L,a Ghirardello A, Zampieri S, Arienti S, Sarzi-Puttini P, et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med. 2006;119(8):700-6.
33. Frassoni F, Labopin M, Powles R, Mary JY, Arcese W, Bacigalupo A, et al. Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet. 2000;355(9213): 1393-8.
34. Centres of Reference for Rare Diseases in Europe: State-of-the-art in 2006 and recommendations of the Rare Diseases Task Force 〈http://ec.europa. eu/health/ph- threats/non-com/docs/contribution-policy. pdf〉.
35. th Edition. 2008 chapter 32: 395-401 Editors J. Apperley, E. Carreras, E. Gluckman, A. Gratwohl, T. Masszi. Forum Service Editor. edit@forumservice.netwww. accmed.org.
36. Petri M, Brodsky R. High-dose cyclophosphamide and stem cell transplantation for refractory systemic lupus erythematosous. JAMA. 2006;295(5):559-60.
37. Radbruch A, Thiel A. Cell therapy for autoimmune diseases: does it have a future? Ann Rheum Dis 2004;63 (Suppl 2):ii96-ii101.
38. Sykes M, Nikolic B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature. 2005;435(7042):620-7.
39. Farge D, Henegar C, Carmagnat M, Danesphouy O, Marjanovic Z, Rabian C, et al. Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis. Arthritis Rheum. 2005; 52:(5)1555-63.
40. Muraro PA, Douek DC, Packer A, Chung K, Guenaga FJ, Cassiani-Ingoni R, et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med. 2005;201(5):805-16.
41. De Kleer I, Vastert B, Klein M, Teklenburg G, Arkesteijn G, Yung GP, et al. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood. 2006;107(4):1696-702.
42. Alexander T, Thiel A, Rosen O, Massenkeil G, Sattler A, Kohler S, et al. Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. Blood. 2009; 113:(1)214-23.
43. Saccardi R, Tyndall A, Coghlan P, Denton C, Edan G, Emdin M, et al. Consensus statement concerning cardiotoxicity occurring during hematopoietic stem cell transplantation of autoimmune disease, with special reference to sytemic sclerosis and multiple sclerosis. Bone Marrow Transplant. 2004; 34(10):877-81.